Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 72 (HNRNPA1P72)

Target
HNRNPA1P72
Molecular classification
Other (pseudogene)
01

Overview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 72 (HNRNPA1P72) is a processed pseudogene—a non-protein-coding DNA sequence with high similarity to the parental HNRNPA1 gene, which encodes an RNA-binding protein involved in RNA metabolism, splicing, and transport[1][3][5]. Unlike its parental gene, HNRNPA1P72 does not code for a functional protein and is not considered a therapeutic target or receptor. Current data do not indicate a direct biological function or disease role for HNRNPA1P72; it is not implicated in drug targeting, disease biomarker usage, or therapeutic safety concerns, and its scientific relevance is limited to genomics and the study of pseudogenes[1][5]. Notes: - HNRNPA1P72 is a *pseudogene* and not a functional protein, receptor, enzyme, or therapeutic target[1][3][5]. - Most scientific and clinical interest in the family pertains to its functional parental gene, HNRNPA1, not HNRNPA1P72. - If searching for a therapeutic or diagnostic target, HNRNPA1 (not the pseudogene 72) is the relevant molecule[2][4]. - There are no recognized interacting drugs, mechanisms of action, biomarkers, associations with disease roles, or specific molecular functions assigned to this pseudogene[1][3][5]. If there are further needs for structured nomenclature or specificity about the parental gene, please clarify if you require data for **Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1)**, which is an active RNA-binding protein involved in various biological and pathological processes[2][4].

Other names
HNRNPA1P72

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 72 (HNRNPA1P72).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 72 (HNRNPA1P72).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call